Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/21/26 21:25 | 1/17/26 | MGTX | Health | BioPrd | Biological Products, (No Diag | Zeldin Robert K | NY | O | CHIEF ME | 2 | M.d | 0 | 0.00 | 0 | 53 | 45 | 168 | D | ||||||||||||||
1/21/26 21:21 | 1/17/26 | MGTX | Health | BioPrd | Biological Products, (No Diag | Wollin Robert J | NY | O | GC,SECRE | 2 | M.d | 0 | 0.00 | 0 | 58 | 52 | D | |||||||||||||||
1/21/26 21:15 | 1/17/26 | MGTX | Health | BioPrd | Biological Products, (No Diag | Naylor Stuart | NY | O | CHIEF DE | 2 | M.d | 0 | 0.00 | 0 | 113 | 20 | 683 | D | ||||||||||||||
1/21/26 21:13 | 1/17/26 | MGTX | Health | BioPrd | Biological Products, (No Diag | Giroux Richard | NY | O | CFO,COO | 2 | M.d | 0 | 0.00 | 0 | 363 | 50 | 1,089 | D | ||||||||||||||
1/21/26 21:10 | 1/17/26 | MGTX | Health | BioPrd | Biological Products, (No Diag | Forbes Alexandria | NY | DO | P,CEO | 2 | M.d | 0 | 0.00 | 0 | 373 | 34 | 1,482 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |